Cargando…

α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease

Currently, there are no reported genetic predictors of motor symptom progression in Parkinson’s disease (PD). In familial PD, disease severity is associated with higher α-synuclein (SNCA) expression levels, and in postmortem studies expression varies with SNCA genetic variants. Furthermore, SNCA is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritz, Beate, Rhodes, Shannon L., Bordelon, Yvette, Bronstein, Jeff
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352914/ https://www.ncbi.nlm.nih.gov/pubmed/22615757 http://dx.doi.org/10.1371/journal.pone.0036199

Ejemplares similares

Medication Responsiveness of Motor Symptoms in a Population-Based Study of Parkinson Disease
por: Bordelon, Yvette M., et al.
Publicado: (2011)

Parkinson’s disease is associated with DNA methylation levels in human blood and saliva
por: Chuang, Yu-Hsuan, et al.
Publicado: (2017)

Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene–Pesticide Interactions in a Case–Control Study of Parkinson’s Disease, California (USA)
por: Paul, Kimberly C., et al.
Publicado: (2015)

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
por: Ritz, Beate R., et al.
Publicado: (2009)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila
por: Gajula Balija, Madhu Babu, et al.
Publicado: (2011)

Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
por: Takamatsu, Yoshiki, et al.
Publicado: (2018)

Ethnicity and Parkinson’s Disease: Motor and Nonmotor Features and Disease Progression in Latino Patients Living in Rural California
por: Duarte Folle, Aline, et al.
Publicado: (2023)

Well-Water Consumption and Parkinson’s Disease in Rural California
por: Gatto, Nicole M., et al.
Publicado: (2009)

Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study
por: Roede, James R., et al.
Publicado: (2013)

DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease
por: Paul, Kimberly C., et al.
Publicado: (2021)

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism
por: Skogar, Orjan, et al.
Publicado: (2018)

α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson’s disease
por: Mazzetti, Samanta, et al.
Publicado: (2020)

Confirmatory Factor Analysis of the Motor Unified Parkinson's Disease Rating Scale
por: Vassar, Stefanie D., et al.
Publicado: (2012)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy
por: Dutta, Suman, et al.
Publicado: (2021)

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
por: Diaw, Sokhna Haissatou, et al.
Publicado: (2023)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

Mechanisms of enhanced aggregation and fibril formation of Parkinson’s disease-related variants of α-synuclein
por: Ohgita, Takashi, et al.
Publicado: (2022)

Exercise-Induced Autophagy Ameliorates Motor Symptoms Progressivity in Parkinson’s Disease Through Alpha-Synuclein Degradation: A Review
por: Goenawan, Hanna, et al.
Publicado: (2023)

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity
por: O’Donnell, Kelley C., et al.
Publicado: (2014)

Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
por: Fan, Zheng, et al.
Publicado: (2020)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
por: Boi, Laura, et al.
Publicado: (2020)

Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants
por: Watt, Kathryn J. C., et al.
Publicado: (2022)

Copper(II) Binding to α-Synuclein, the Parkinson’s Protein
por: Lee, Jennifer C., et al.
Publicado: (2008)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p54e6knd8gen8cf2avrh4ajo9v